Now accepting Telehealth appointments. Schedule a virtual visit.

Skip to main content

PGT-A, costly and unreliable yet marketed vigorously [PR]

Dr. Gleicher joins two prominent colleagues in warning against the widespread utilization of PGT-A, in an opinion paper just published in Trends in Molecular Medicine. Learn more in our press release here.

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

The September Voice 2023

After our annual summer break during July and August, we welcome you reenergized and ready to rock’n’roll with our September issue into the new academic year 2023/2024.

LGBTQ+ Family Planning: 5 Options for Having a Baby

LGBTQ+ family planning may require a special approach. Thankfully, there are enough options available that there’s sure to be one right for you and your family. Here are five options we offer for LGBTQ+ individuals to expand their family.

The CHR June Voice

We are pleased to publish our June Voice, The CHR VOICE. This is the last issue for the 2022/2023 academic year before we take a publication break during July and August (unless really something very important is happening).